Literature DB >> 12568408

Relative contributions of bone density, bone turnover, and clinical risk factors to long-term fracture prediction.

L Joseph Melton1, Cynthia S Crowson, W Michael O'Fallon, Heinz W Wahner, B Lawrence Riggs.   

Abstract

Long-term fracture prediction using bone mineral density remains controversial, as does the additional contribution from assessing bone turnover or clinical risk factors. We measured bone mineral density at various sites, along with biochemical markers of bone turnover, sex steroid levels, and over 100 clinical variables, at baseline on an age-stratified sample of 304 Rochester, MN women in 1980. The 225 postmenopausal women were subsequently followed for 3146 person-years (median, 16.2 years per subject), wherein they experienced 302 new fractures: 81% resulted from minimal or moderate trauma and 60% of these involved the proximal femur, thoracic or lumbar vertebrae, or distal forearm. Accounting for multiple fractures per subject, these osteoporotic fractures together were best predicted by baseline femoral neck bone mineral density (age-adjusted hazard ratio [HR] per SD decrease, 1.37; 95% CI, 1.10-1.70); 19 moderate trauma forearm fractures were best predicted by distal radius bone mineral content, whereas 28 hip fractures and 100 vertebral fractures were best predicted by femoral neck bone mineral density. Femoral neck bone mineral density performed comparably in predicting osteoporotic fracture risk within the first decade of follow-up (HR, 1.38; 95% CI, 1.10-1.74) as well as more than 10 years after baseline (HR, 1.39; 95% CI, 1.05-1.84). The older biochemical markers were not associated with fractures, but serum "free" estradiol index was independently predictive of short- and long-term fracture risk. Consistent clinical risk factors were not identified, but statistical power was limited. Identifying patients at increased long-term risk of fracture is challenging, but it is reassuring that femoral neck bone mineral density can predict osteoporotic fractures up to 20 years later.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12568408     DOI: 10.1359/jbmr.2003.18.2.312

Source DB:  PubMed          Journal:  J Bone Miner Res        ISSN: 0884-0431            Impact factor:   6.741


  47 in total

1.  Considerations for development of surrogate endpoints for antifracture efficacy of new treatments in osteoporosis: a perspective.

Authors:  Mary L Bouxsein; Pierre D Delmas
Journal:  J Bone Miner Res       Date:  2008-08       Impact factor: 6.741

2.  BMD, clinical risk factors and their combination for hip fracture prevention.

Authors:  H Johansson; J A Kanis; A Oden; O Johnell; E McCloskey
Journal:  Osteoporos Int       Date:  2009-03-17       Impact factor: 4.507

Review 3.  Tea and bone health: steps forward in translational nutrition.

Authors:  Chwan-Li Shen; Ming-Chien Chyu; Jia-Sheng Wang
Journal:  Am J Clin Nutr       Date:  2013-10-30       Impact factor: 7.045

4.  Birth weight is more important for peak bone mineral content than for bone density: the PEAK-25 study of 1,061 young adult women.

Authors:  M Callréus; F McGuigan; K Åkesson
Journal:  Osteoporos Int       Date:  2012-07-18       Impact factor: 4.507

5.  Osteoporosis practice patterns in 2006 among primary care physicians participating in the NORA study.

Authors:  T W Weiss; E S Siris; E Barrett-Connor; P D Miller; C A McHorney
Journal:  Osteoporos Int       Date:  2007-06-19       Impact factor: 4.507

6.  Prediction of changes in bone mineral density in postmenopausal women treated with once-weekly bisphosphonates.

Authors:  Sherri-Ann M Burnett-Bowie; Kenneth Saag; Anthony Sebba; Anne E de Papp; Erluo Chen; Elizabeth Rosenberg; Susan L Greenspan
Journal:  J Clin Endocrinol Metab       Date:  2009-01-13       Impact factor: 5.958

7.  Combining bone resorption markers and heel quantitative ultrasound to discriminate between fracture cases and controls.

Authors:  D Nanchen; J Cornuz; C Ruffieux; W Riesen; P Burckhardt; M A Krieg
Journal:  Osteoporos Int       Date:  2009-01-31       Impact factor: 4.507

8.  Differential regulation of dehydroepiandrosterone and estrogen on bone and uterus in ovariectomized mice.

Authors:  L Wang; Y-D Wang; W-J Wang; D-J Li
Journal:  Osteoporos Int       Date:  2008-08-09       Impact factor: 4.507

9.  Association of bone turnover markers with volumetric bone loss, periosteal apposition, and fracture risk in older men and women: the AGES-Reykjavik longitudinal study.

Authors:  E A Marques; V Gudnason; T Lang; G Sigurdsson; S Sigurdsson; T Aspelund; K Siggeirsdottir; L Launer; G Eiriksdottir; T B Harris
Journal:  Osteoporos Int       Date:  2016-06-24       Impact factor: 4.507

10.  Biochemical markers for bone turnover predict risk of vertebral fractures in postmenopausal women over 10 years: the Japanese Population-based Osteoporosis (JPOS) Cohort Study.

Authors:  J Tamaki; M Iki; E Kadowaki; Y Sato; Y Chiba; T Akiba; T Matsumoto; H Nishino; S Kagamimori; Y Kagawa; H Yoneshima
Journal:  Osteoporos Int       Date:  2012-08-11       Impact factor: 4.507

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.